The Valley Desk

NCT03479307 · Interventional trial

A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Overall registry status Completed

Phase 3

Conditions Allergic Conjunctivitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov